Dengue in India

Indian Journal of Medical Research

Volumn 136, Issue 3, 2012, Pages 373-390

  Gupta, Nivedita ^a   Srivastava, Sakshi ^b   Jain, Amita ^b   Chaturvedi, Umesh C ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b UNIVERSITY OF LUCKNOW   (India)

Author keywords

Aedes mosquitoes; Dengue; Dengue vaccine; DF DHF; DV; Flaviviridae; Pathogenesis

Indexed keywords

CYTOTOXIC FACTOR; DENGUE VACCINE; DRINKING WATER; IMMUNOGLOBULIN M ANTIBODY; RECOMBINANT ANTIGEN; VIRUS ANTIGEN;

ACUTE KIDNEY FAILURE; ACUTE LIVER FAILURE; AMINO TERMINAL SEQUENCE; BRAIN EDEMA; CAPILLARY LEAK SYNDROME; CD4+ T LYMPHOCYTE; DENGUE; DENGUE VIRUS; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; ESCHERICHIA COLI; GASTROINTESTINAL HEMORRHAGE; GUILLAIN BARRE SYNDROME; HEART INJURY; HELPER CELL; HEPATIC ENCEPHALOPATHY; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INDIA; MACULOPAPULAR RASH; MEGAKARYOCYTE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEURITIS; PERIODIC PARALYSIS; PHILIPPINES; PICHIA PASTORIS; QUADRIPLEGIA; REVIEW; SEIZURE; SEROTYPE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; VECTOR CONTROL; VIRAL GENETICS; VIRUS GENE; VIRUS ISOLATION; VIRUS STRAIN;

DENGUE; DENGUE VIRUS; HUMANS; INDIA;

EID: 84867149959     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (239)

1. Whitehorn J, Farrar J. Dengue. Br Med Bull 2010; 95: 161-73.
2. WHO. Dengue: Guidelines for diagnosis, treatment, prevention, and control in sub-Saharan Africa and 13 countries in South America. Geneva: World Health Organization; 2009.
3. Kimura R, Hotta S. Studies on dengue fever (IV) on inoculation of dengue virus into mice. Nippon Igaku 1944; 3379: 629-33.
4. Sabin AB, Schlesinger MC. Production of immunity to dengue with virus modified by propagation in mice. Science 1945; 101: 640-2.
5. Sarkar JK, Chatterjee SN, Chakravarty SK. Haemorrhagic fever in Calcutta: some epidemiological observations. Indian J Med Res 1964; 52: 651-9.
6. Chatterjee SN, Chakravarti SK, Mitra AC, Sarkar JK. Virological investigation of cases with neurological complications during the outbreak of haemorrhagic fever in Calcutta. J Indian Med Assoc 1965; 45: 314-6.
7. Carey DE, Myers RM, Reuben R, Rodrigues FM. Studies on dengue in Vellore, South India. Am J Trop Med Hyg 1966; 15: 580-7.
8. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue hemorrhagic fever. Lancet 1998; 352: 971-7.
9. Kabra SK, Verma IC, Arora NK, Jain Y, Kalra V. Dengue haemorrhagic fever in children in Delhi. Bull World Health Organ 1992; 70: 105-8.
10. Bhattacharjee N, Mukherjee KK, Chakravarti SK, Mukherjee MK, De PN, Sengupta M, et al. Dengue haemorrhagic fever (DHF) outbreak in Calcutta-1990. J Commun Dis 1993; 25: 10-4.
11. Cherian T, Ponnuraj E, Kuruvilla T, Kirubakaran C, John TJ, Raghupathy P. An epidemic of dengue haemorrhagic fever & dengue shock syndrome in & around Vellore. Indian J Med Res 1994; 100: 51-6.
12. Dar L, Broor S, Sengupta S, Xess I, Seth P. The first major outbreak of dengue hemorrhagic fever in Delhi, India. Emerg Infect Dis 1999; 5: 589-90.
13. Agarwal R, Kapoor S, Nagar R, Misra A, Tandon R, Mathur A, et al. A clinical study of the patients with dengue hemorrhagic fever during the epidemic of 1996 at Lucknow, India. Southeast Asian J Trop Med Public Health 1999; 30: 735-40.
14. Shah I, Deshpande GC, Tardeja PN. Outbreak of dengue in Mumbai and predictive markers for dengue shock syndrome. J Trop Pediatr 2004; 50: 301-5.
15. Karamchandani PV. Dengue group of fevers in India. Lancet 1946; 1: 92.
16. Ramakrishanan SP, Gelfand HM, Bose PN, Sehgal PN, Mukharjee RN. The epidemic of acute haemorrhagic fever, Calcutta, 163: epidemiological inquiry. Indian J Med Res 1964; 52: 633-50.
17. Sarkar JK, Pavri KM, Chatterjee SN, Chakravarty SK, Aanderson CR. Virological and serological studies of cases of haemorrhagic fever in Calcutta. Indian J Med Res 1964; 52: 684-91.
18. Chaudhuri RN, Saha TK, Chaudhuri AD. Dengue-like fever in Calcutta: further preliminary observations. Bull Calcutta Sch Trop Med 1965; 13: 2-3.
19. Krishnamurthy K, Kasturi TE, Chittipantulu G. Clinical and pathological studies of an outbreak of dengue-like illness in Visakhapatnam. Indian J Med Res 1965; 53: 800-12.
20. Paul SD, Dandawate CN, Banerjee K, Krishnamurthy K. Virological and serological studies on an outbreak of dengue-like illness in Visakhapatnam, Andhra Pradesh. Indian J Med Res 1965; 53: 777-89.
21. Balaya S, Paul SD, D'Lima LV, Pavri KM. Investigations on an outbreak of dengue in Delhi in 1967. Indian J Med Res 1969; 57: 767-74.
22. Chaturvedi UC, Mathur A, Kapoor AK, Mehrotra NK, Mehrotra RML. Virological study of an epidemic of febrile illness with haemorrhagic manifestations at Kanpur, India, during 1968. Bull World Health Organ 1970; 43: 289-93.
23. Chaturvedi UC, Kapoor AK, Mathur A, Chandra D, Khan AM, Mehrotra RML. A clinical and epidemiological study of an epidemic of febrile illness with haemorrhagic manifestations which occurred at Kanpur, India in 1968. Bull World Health Organ 1970; 43: 281-7.
24. Myers RM, Carey DE, Banerjee K, Reuben R, Ramamurti DV. Recovery of dengue type 3 virus from human serum and Aedes aegypti in South India. Indian J Med Res 1968; 56: 781-7.
25. Ghosh BN. A study on the epidemic of dengue-like fever in Pondicherry (1964-65 and 1965-66). J Indian Med Assoc 1968; 51: 261-4.
26. Chaturvedi UC, Mathur A, Kapoor AK, Tandon HO, Mehrotra RML. Clinicovirological study of the recurrence of dengue epidemic with haemorrhagic manifestation at Kanpur, during 1969. Indian J Med Res 1972; 60: 329-33.
27. Chaturvedi UC, Mathur A, Mehrotra RM. Experimentally produced cardiac injury following dengue virus infection. Indian J Pathol Bacteriol 1974; 17: 218-20.
28. Myers RM, Carey DE, De Ranitz CM, Reuben R, Bennet B. Virological investigations of the 1966 outbreak of Dengue type 3 in Vellore, Southern India. Indian J Med Res 1969; 57: 1392-401.
29. Myers RM, Varkey MJ, Reuben R, Jesudass ES. Dengue outbreak in Vellore, southern India, in 1968, with isolation of four dengue types from man and mosquitoes. Indian J Med Res 1970; 58: 24-30.
30. Myers RM, Varkey MJ. A note on sequential dengue infection, presumptive and proved, with report of an instance of a third proved attack in one individual. Indian J Med Res 1971; 59: 1231-6.
31. Mahadev PV, Kollali VV, Rawal ML, Pujara PK, Shaikh BH, Ilkal MA, et al. Dengue in Gujarat state, India during 1988 & 1989. Indian J Med Res 1993; 97: 135-44.
32. Ghosh SN, Pavri KM, Singh KR, Sheikh BH, D'lima LV, Mahadev PV, et al. Investigations on the outbreak of dengue fever in Ajmer City, Rajasthan State in 1969. Part I. Epidemiological, clinical and virological study of the epidemic. Indian J Med Res 1974; 62: 511-22.
33. Chouhan GS, Rodrigues FM, Shaikh BH, Ilkal MA, Khangaro SS, Mathur KN, et al. Clinical & virological study of dengue fever outbreak in Jalore city, Rajasthan 1985. Indian J Med Res 1990; 91: 414-8.
34. Rodrigues FM, Pavri KM, Dandawate CN, Banerjee K, Bhatt PN. An investigation of the aetiology of the 1966 outbreak of febrile illness in Jabalpur, Madhya Pradesh. Indian J Med Res 1973; 61: 1462-70.
35. Kumar A, Sharma SK, Padbidri VS, Thakare JP, Jain DC, Datta KK. An outbreak of dengue fever in rural areas of northern India. J Commun Dis 2001; 33: 274-81.
36. Parida MM, Dash PK, Upadhyay C, Saxena P, Jana AM. Serological & virological investigation of an outbreak of dengue fever in Gwalior, India. Indian J Med Res 2002; 116: 248-54.
37. Kurukumbi M, Wali JP, Broor S, Aggarwal P, Seth P, Handa R, et al. Seroepidemiology and active surveillance of dengue fever/dengue haemorrhagic fever in Delhi. Indian J Med Sci 2001; 55: 149-56.
38. Singh UB, Maitra A, Broor S, Rai A, Pasha ST, Seth P. Partial nucleotide sequencing and molecular evolution of epidemic causing dengue 2 strains. J Infect Dis 1999; 180: 959-65.
39. Dash PK, Parida MM, Saxena P, Kumar M, Rai A, Pasha ST, et al. Emergence and continued circulation of dengue-2 (genotype IV) virus strains in northern India. J Med Virol 2004; 74: 314-22.
40. Anoop M, Issac A, Mathew T, Philip S, Kareem NA, Unnikrishnan R, et al. Genetic characterization of dengue virus serotypes causing concurrent infection in an outbreak in Ernakulam, Kerala, South India. Indian J Exp Biol 2010; 48: 849-57.
41. Mukherjee KK, Chakravarti SK, Dey PN, Dey S, Chakraborty MS. Outbreak of febrile illness due to dengue virus type 3 in Calcutta during 1983. Trans R Soc Trop Med Hyg 1987; 81: 1008-10.
42. Dash PK, Saxena P, Abhyankar A, Bhargava R, Jana AM. Emergence of dengue virus type-3 in northern India. Southeast Asian J Trop Med Public Health 2005; 36: 370-7.
43. Dash PK, Saxena P, Abhyankar A, Bhargava R, Jana AM. Reemergence of dengue virus type-3 (subtype-III) in India: implications for increased incidence of DHF & DSS. Virol J 2006; 3: 55-65.
44. Paramasivan R, Thenmozhi V, Thangaratham PS, Rajendran R, Tewari SC, Dhananjeyan KJ, et al. An outbreak of dengue fever in Tirupur, Coimbatore district, Tamil Nadu. Indian J Med Res 2010; 132: 105-7.
45. Dash PK, Sharma S, Srivastava A, Santhosh SR, Parida MM, Neeraja M, et al. Emergence of dengue virus type 4 (genotype I) in India. Epidemiol Infect 2011; 139: 857-61.
46. Dayaraj C, Kakade MB, Bhagat AB, Vallentyne J, Singh A, Patil JA, et al. Detection of dengue-4 virus in Pune, western India after an absence of 30 years-its association with two severe cases. Virol J 2011; 8: 46-9.
47. Dar L, Gupta E, Narang P, Broor S. Cocirculation of dengue serotypes, Delhi, India, 2003. Emerg Infect Dis 2006; 12: 352-3.
48. Gupta E, Dar L, Kapoor G, Broor S. The changing epidemiology of dengue in Delhi, India. Virol J 2006; 3: 92-6.
49. Kukreti H, Chaudhary A, Rautela RS, Anand R, Mittal V, Chhabra M, et al. Emergence of an independent lineage of dengue virus type 1 (DENV-1) and its co-circulation with predominant DENV-3 during the 2006 dengue fever outbreak in Delhi. Int J Infect Dis 2008; 12: 542-9.
50. Bharaj P, Chahar HS, Pandey A, Diddi K, Dar L, Guleria R, et al. Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India. Virol J 2008; 5: 1.
51. Chakravarti A, Kumar A, Matlani M. Displacement of dengue virus type 3 and type 2 by dengue virus type 1 in Delhi during 2008. Indian J Med Microbiol 2010; 28: 412-3.
52. Myers RM, Carey DE. Concurrent isolation from patient of two arboviruses, Chikungunya and dengue type 2. Science 1967; 157: 1307-8.
53. Chahar HS, Bharaj P, Dar L, Guleria R, Kabra SK, Broor S. Co-infections with chikungunya virus and dengue virus in Delhi, India. Emerg Infect Dis 2009; 15: 1077-80.
54. Mehendale SM, Risbud AR, Rao JA, Banerjee K. Outbreak of dengue fever in rural areas of Parbhani district of Maharashtra (India). Indian J Med Res 1991; 93: 6-11.
55. Padbidri VS, Adhikari P, Thakare JP, Ilkal MA, Joshi GD, Pereira P, et al. The 1993 epidemic of dengue fever in Mangalore, Karnataka state, India. Southeast Asian J Trop Med Public Health 1995; 26: 699-704.
56. Barua HC, Mahanta J. Serological evidence of DEN-2 activity in Assam and Nagaland. J Commun Dis 1996; 28: 56-8.
57. Kaur H, Prabhakar H, Mathew P, Marshalla R, Arya M. Dengue haemorrhagic fever outbreak in October-November 1996 in Ludhiana, Punjab, India. Indian J Med Res 1997; 106: 1-3.
58. Aggarwal A, Chandra J, Aneja S, Patwari AK, Dutta AK. An epidemic of dengue hemorrhagic fever and dengue shock syndrome in children in Delhi. Indian Pediatr 1998; 35: 727-32.
59. Kabra SK, Jain Y, Pandey RM, Madhulika, Singhal T, Tripathi P, et al. Dengue haemorrhagic fever in children in the 1996 Delhi epidemic. Trans R Soc Trop Med Hyg 1999; 93: 294-8.
60. Vajpayee M, Mohankumar K, Wali JP, Dar L, Seth P, Broor S. Dengue virus infection during post-epidemic period in Delhi, India. Southeast Asian J Trop Med Public Health 1999; 30: 507-10.
61. Joshi PT, Pandya AP, Anjan JK. Epidemiological and entomological investigation in dengue outbreak area of Ahmedabad district. J Commun Dis 2000; 32: 22-7.
62. Singh UB, Seth P. Use of nucleotide sequencing of the genomic cDNA fragments of the capsid/premembrane junction region for molecular epidemiology of dengue type 2 viruses. Southeast Asian J Trop Med Public Health 2001; 32: 326-35.
63. Victor TJ, Malathi M, Gurusamy D, Desai A, Ravi V, Narayanasamy G, et al. Dengue fever outbreaks in two villages of Dharmapuri district in Tamil Nadu. Indian J Med Res 2002; 116: 133-9.
64. Padbidri VS, Wairagkar NS, Joshi GD, Umarani UB, Risbud AR, Gaikwad DL, et al. A serological survey of arboviral diseases among the human population of the Andaman and Nicobar Islands, India. Southeast Asian J Trop Med Public Health 2002; 33: 794-800.
65. Kabilan L, Velayutham T, Sundaram B, Tewari SC, Natarajan A, Rathnasamy R, et al. Field-and laboratory-based active dengue surveillance in Chennai, Tamil Nadu, India: observations before and during the 2001 dengue epidemic. Am J Infect Control 2004; 32: 391-6.
66. Hati AK. Studies on dengue and dengue haemorrhagic fever (DHF) in West Bengal State, India. J Commun Dis 2006; 38: 124-9.
67. Paramasivanet R, Thenmozhi V, Hiriyan J, Dhananjeyan K, Tyagi B, Dash AP. Serological and entomological investigations of an outbreak of dengue fever in certain rural areas of Kanyakumari district, Tamil Nadu. Indian J Med Res 2006; 123: 697-701.
68. Kukreti H, Dash PK, Parida M, Chaudhary A, Saxena P, Rautela RS, et al. Phylogenetic studies reveal existence of multiple lineages of a single genotype of DENV-1 (genotype III) in India during 1956-2007. Virol J 2009; 6: 1-9.
69. Kumar SR, Patil JA, Cecilia D, Cherian SS, Barde PV, Walimbe AM, et al. Evolution, dispersal and replacement of American genotype dengue type 2 viruses in India (1956-2005): selection pressure and molecular clock analyses. J Gen Virol 2010; 91: 707-20.
70. Kumaria R. Correlation of disease spectrum among four Dengue serotypes: a five years hospital based study from India. Braz J Infect Dis 2010; 14: 141-6.
71. Kukreti H, Mittal V, Chaudhary A, Rautela RS, Kumar M, Chauhan S, et al. Continued persistence of a single genotype of dengue virus type-3 (DENV-3) in Delhi, India since its re-emergence over the last decade. J Microbiol Immunol Infect 2010; 43: 53-61.
72. Paramasivan R, Dhananjeyan KJ, Leo SV, Muniaraj M, Thenmozhi V, Rajendran R, et al. Dengue fever caused by dengue virus serotype-3 (subtype-III) in a rural area of Madurai district, Tamil Nadu. Indian J Med Res 2010; 132: 339-42.
73. Sharma S, Dash PK, Agarwal S, Shukla J, Parida MM, Rao PV. Comparative complete genome analysis of dengue virus type 3 circulating in India between 2003 and 2008. J Gen Virol 2011; 92: 1595-600.
74. Matlani M, Chakravarti A. Changing trends of dengue disease: a brief report from a tertiary care hospital in New Delhi. Braz J Infect Dis 2011; 15: 184-5.
75. Patil JA, Cherian S, Walimbe AM, Patil BR, Sathe PS, Shah PS, et al. Evolutionary dynamics of the American African genotype of dengue type 1 virus in India (1962-2005). Infect Genet Evol 2011; 11: 1443-8.
76. Chaturvedi UC, Bhardwaj OP, Mathur A, Bahuguna LM, Mehrotra RML. Erythrocytic factors and viral haemagglutination. Indian J Med Res 1970; 58: 1217-25.
77. Misra UK, Kalita J, Syam UK, Dhole TN. Neurological manifestations of dengue virus infection. J Neurol Sci 2006; 244: 117-22.
78. Verma R, Sharma P, Garg RK, Atam V, Singh MK, Mehrotra HS. Neurological complications of dengue fever: Experience from a tertiary center of north India. Ann Indian Acad Neurol 2011; 14: 272-8.
79. Kumar R, Tripathi S, Tambe JJ, Arora V, Srivastava A, Nag VL. Dengue encephalopathy in children in Northern India: clinical features and comparison with non dengue. J Neurol Sci 2008; 269: 41-8.
80. Verma R, Varatharaj A. Epilepsia partialis continua as a manifestation of dengue encephalitis. Epilepsy Behav 2011; 20: 395-7.
81. Deepak NA, Patel ND. Differential diagnosis of acute liver failure in India. Ann Hepatol 2006; 5: 150-6.
82. Vinodh BN, Bammigatti C, Kumar A, Mittal V. Dengue fever with acute liver failure. J Postgrad Med 2005; 51: 322-3.
83. Giri S, Agarwal MP, Sharma V, Singh A. Acute hepatic failure due to dengue: A case report. Cases J 2008; 1: 204.
84. Jhamb R, Kashyap B, Ranga GS, Kumar A. Dengue fever presenting as acute liver failure-a case report. Asian Pac J Trop Med 2011; 4: 323-4.
85. Kabra SK, Juneja R, Madhulika, Jain Y, Singhal T, Dar L, et al. Myocardial dysfunction in children with dengue haemorrhagic fever. Natl Med J India 1988; 11: 59-61.
86. Acharya S, Shukla S, Mahajan SN, Diwan SK. Acute dengue myositis with rhabdomyolysis and acute renal failure. Ann Indian Acad Neurol 2010; 13: 221-2.
87. Kalita J, Misra UK, Mahadevan A, Shankar SK. Acute pure motor quadriplegia: is it dengue myositis? Electromyogr Clin Neurophysiol 2005; 45: 357-61.
88. Wali JP, Biswas A, Chandra S, Malhotra A, Aggarwal P, Handa R, et al. Cardiac involvement in dengue haemorrhagic fever. Int J Cardiol 1998; 64: 31-6.
89. Kaushik JS, Gupta P, Rajpal S, Bhatt S. Spontaneous resolution of sinoatrial exit block and atrioventricular dissociation in a child with dengue fever. Singapore Med J 2010; 51: e146-8.
90. Harris VK, Danda D, Murali NS, Das PK, Abraham M, Cherian AM, et al. Unusual association of Kikuchi's disease and dengue virus infection evolving into systemic lupus erythematosus. J Indian Med Assoc 2000; 98: 391-3.
91. Rajadhyaksha A, Mehra S. Dengue fever evolving into systemic lupus erythematosus and lupus nephritis: a case report. Lupus 2012; 21: 999-1002.
92. Kanungo S, Shukla D, Kim R. Branch retinal artery occlusion secondary to dengue fever. Indian J Ophthalmol 2008; 56: 73-4.
93. Soundravally R, Sankar P, Bobby Z, Hoti SL. Oxidative stress in severe dengue viral infection: association of thrombocytopenia with lipid peroxidation. Platelets 2008; 19: 447-54.
94. Soundravally R, Sankar P, Hoti SL, Selvaraj N, Bobby Z, Sridhar MG. Oxidative stress induced changes in plasma protein can be a predictor of imminent severe dengue infection. Acta Trop 2008; 106: 156-61.
95. Motla M, Manaktala S, Gupta V, Aggarwal M, Bhoi SK, Aggarwal P, et al. Sonographic evidence of ascites, pleura-pericardial effusion and gallbladder wall edema for dengue fever. Prehosp Disaster Med 2011; 26: 335-41.
96. Upadhaya BK, Sharma A, Khaira A, Dinda AK, Agarwal SK, Tiwari SC. Transient IgA nephropathy with acute kidney injury in a patient with dengue fever. Saudi J Kidney Dis Transpl 2010; 21: 521-5.
97. Rama Krishna AK, Patil S, Srinivas Rao G, Kumar A. Dengue fever presenting with acute colitis. Indian J Gastroenterol 2006; 25: 97-8.
98. Thomas EA, John M, Bhatia A. Cutaneous manifestations of dengue viral infection in Punjab (north India). Int J Dermatol 2007; 46: 715-9.
99. Thomas EA, John M, Kanish B. Mucocutaneous manifestations of dengue fever. Indian J Dermatol 2010; 55: 79-85.
100. Singh S, Jat KR, Suri D, Ratho RK. Dengue fever and Kawasaki disease: a clinical dilemma. Rheumatol Int 2009; 29: 717-9.
101. Jain D, Singh T. Dengue virus related hemophagocytosis: a rare case report. Hematology 2008; 13: 286-8.
102. Ray S, Kundu S, Saha M, Chakrabarti P. Hemophagocytic syndrome in classic dengue fever. J Glob Infect Dis 2011; 3: 399-401.
103. Kapdi M, Shah I. Dengue and haemophagocytic lymphohistiocytosis. Scand J Infect Dis 2012; 44: 708-9.
104. Chaturvedi UC, Tandon P, Mathur A. Effect of immunosuppression on dengue virus infection in mice. J Gen Virol 1977; 36: 449-58.
105. Chaturvedi UC, Mathur A, Tandon P. Host defence mechanisms against dengue virus infection of mice. J Gen Virol 1978; 39: 293-302.
106. Chaturvedi UC, Shukla MI, Mathur KR, Mathur A. Dengue virus-induced cytotoxic factor suppresses immune response of mice to sheep RBC. Immunology 1981; 43: 311-6.
107. Rizvi N, Chaturvedi UC, Nagar R, Mathur A. Macrophage functions during dengue virus infection: antigenic stimulation of B cells. Immunology 1987; 62: 493-8.
108. Rizvi N, Chaturvedi UC, Mathur A. Obligatory role of macrophages in dengue virus antigen presentation to B lymphocytes. Immunology 1989; 67: 38-43.
109. Rizvi N, Chaturvedi UC, Mathur A. Antigenic competition between dengue and Coxsackie viruses for presentation to B cells by macrophages. Int J Exp Pathol 1990; 71: 761-70.
110. Rizvi N, Chaturvedi UC, Mathur A. Inhibition of the presentation of dengue virus antigen by macrophages to B cells by serine-protease inhibitors. Int J Exp Pathol 1991; 72: 23-9.
111. Chaturvedi UC, Pahwa M, Mathur A. Dengue virus-induced helper T cells. Indian J Med Res 1987; 86: 1-8.
112. Chaturvedi P, Mukherjee R, Chaturvedi UC, Mathur A. Characterization of the dengue virus-induced helper cytokine. Int J Exp Pathol 1992; 73: 263-72.
113. Chaturvedi P, Mukherjee R, Chaturvedi UC, Mathur A. Dengue virus-induced helper cytokine has two polypeptide chains which bear different determinants. Int J Exp Pathol 1991; 72: 665-72.
114. Chaturvedi UC, Dhawan R, Khanna M, Mathur A. Breakdown of the blood-brain barrier during dengue virus infection of mice. J Gen Virol 1991; 72: 859-66.
115. Chaturvedi P, Chaturvedi UC, Mukherjee R. Transmission of dengue virus-induced helper signal to B cell via macrophages. Int J Exp Pathol 1992; 73: 773-82.
116. Rizvi N, Chaturvedi P, Chaturvedi UC. Bindings of macrophages and B lymphocytes mediated by dengue virus antigen and the virus-induced helper cytokine. Int J Exp Pathol 1993; 74: 187-94.
117. Tandon P, Chaturvedi UC, Mathur A. Dengue virus-induced thymus-derived suppressor cells in the spleen of mice. Immunology 1979; 38: 653-8.
118. Shukla MI, Chaturvedi UC. Dengue virus-induced suppressor factor stimulates production of prostaglandin to mediate suppression. J Gen Virol 1981; 66: 241-9.
119. Shukla MI, Chaturvedi UC. In vivo role of macrophages in transmission of dengue virus-induced suppressor signal to T lymphocytes. Br J Exp Pathol 1982; 63: 522-30.
120. Shukla MI, Chaturvedi UC. Transmission of dengue virus-induced suppressor signal from macrophage to lymphocyte occurs by cell contact. Br J Exp Pathol 1983; 64: 87-92.
121. Chaturvedi UC, Shukla MI. Characterization of the suppressor factor produced in the spleen of dengue virus-infected mice. Ann Immunol Pasteur Institute 1981; 132: 245-55.
122. Chaturvedi UC, Shukla MI, Mathur A. Thymus dependent lymphocytes of the dengue virus-infected mice spleen mediates suppression through prostaglandin. Immunology 1981; 42: 1-6.
123. Chaturvedi UC. Dengue virus-induced suppressor pathway. Curr Sci 1984; 53: 971-6.
124. Nagarkatti PS, Nagarkatti M. Effect of experimental dengue virus infection on immune response of the host. I. Nature of changes in T suppressor cell activity regulating the B and T cell responses to heterologous antigens. J Gen Virol 1983; 64: 1441-7.
125. Chaturvedi UC, Shrivastava S, Tripathi RK, Nagar, R. Dengue virus-specific suppressor T cell: Current perspectives. FEMS Immunol Med Microbiol 2007; 50: 285-99.
126. Chaturvedi UC, Bhargava A, Mathur A. Production of cytotoxic factor in the spleen of dengue virus infected mice. Immunology 1980; 40: 665-71.
127. Chaturvedi UC, Dalakoti H, Mathur A. Characterization of the cytotoxic factor produced in the spleen of dengue virus-infected mice. Immunology 1980; 41: 387-392.
128. Chaturvedi UC, Nagar R, Mathur A. Effect of dengue virus infection on Fc-receptor functions of mouse macrophages. J Gen Virol 1983; 64: 2399-407.
129. Nagar R, Chaturvedi UC, Mathur A. Effect of dengue virus-induced cytotoxic factor on Fc-receptor functions of mouse macrophages. Br J Exp Pathol 1984; 65: 11-7.
130. Khanna M, Chaturvedi UC, Mathur A. Abrogation of helper T cells by dengue virus-induced cytotoxic factor. Curr Sci 1988; 57: 411-4.
131. Khanna M, Chaturvedi UC, Mathur A. Proteinase-like activity in the cytotoxic factor produced by T cells during dengue virus infection. Immunology 1989; 67: 32-7.
132. Khanna M, Chaturvedi UC, Sharma MC, Pandey VC, Mathur A. Increased capillary permeability mediated by a dengue virus-induced lymphokine. Immunology 1990; 69: 449-54.
133. Khanna M, Chaturvedi UC, Dhawan R, Tekwani BD, Pandey VC. Presence of Ca2+ is obligatory for the cytotoxic activity of dengue virus induced cytotoxic factor. Immunology 1991; 72: 73-8.
134. Khanna M, Chaturvedi UC. Purification and aminoterminal sequence of the dengue virus-induced cytotoxic factor. Int J Exp Pathol 1992; 73: 43-9.
135. Chaturvedi UC, Mukerjee R, Dhawan R. Active immunization by a dengue virus-induced cytokine. Clin Exp Immunol 1994; 96: 202-7.
136. Mukerjee R, Chaturvedi UC, Vaughn DW, Kalayanarooj S. Purification and pathogenicity of the cytotoxic factor from the cases of dengue haemorrhagic fever. Curr Sci 1997; 72: 494-501.
137. Agarwal R, Chaturvedi UC, Misra A, Mukerjee R, Kapoor S, Nagar R, et al. Production of cytotoxic factor by peripheral blood mononuclear cells (PBMC) in patients with dengue haemorrhagic fever. Clin Exp Immunol 1998; 112: 340-4.
138. Mills KHG. Regulatory T cells: Friend or foe in immunity to infection? Nat Rev Immunol 2004; 4: 841-55.
139. Chaturvedi UC, Elbishbishi EA, Agarwal R, Raghupathy R, Nagar R, Tandon R, et al. Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures. J Med Virol 1999; 59: 335-40.
140. Chaturvedi UC, Nagar R. Dengue and dengue haemorrhagic fever: Indian perspective. J Biosci 2008; 33: 429-41.
141. Bhargava A, Chaturvedi UC, Srivastava N, Mathur A. Dengue virus-induced suppressor factor has two disulphide-bonded chains which bears anti-idiotypicc and I-A and I-J determinants. Curr Sci 1990; 58: 157-60.
142. Mukherjee R, Chaturvedi P, Chaturvedi UC. Identification of a receptor on macrophages for the dengue virus-induced suppressor cytokine. Clin Exp Immunol 1993; 91: 257-65.
143. Mukherjee R, Chaturvedi P, Chaturvedi UC. Binding of the two polypeptide chains of dengue virus-induced suppressor cytokine to its receptor isolated from macrophages. Int J Exp Pathol 1993; 74: 259-66.
144. Mukherjee R, Chaturvedi P, Chaturvedi UC. Specific receptor for dengue virus-induced suppressor cytokine on macrophages and lymphocytes. Int J Exp Pathol 1994; 75: 29-36.
145. Tripathi RK, Khare M, Chaturvedi UC. Internalization of dengue virus-induced suppressor cytokine during transmission of the suppressor signal via macrophage. Indian J Exp Biol 1997; 35: 850-4.
146. Chaturvedi UC, Shukla MI, Mathur A. Role of macrophage in transmission of dengue virus-induced suppressor signal to a subpopulation of T lymphocytes. Ann Immunol (Pasteur Institute) 1982; 133 C: 83-96.
147. Shukla MI, Chaturvedi UC. Study of the target cell of the dengue virus-induced suppressor signal. Br J Exp Pathol 1984; 65: 267-73.
148. Shukla MI, Chaturvedi UC. Differential cyclophosphamide sensitivity of T lymphocytes of the dengue virus-induced suppressor pathway. Br J Exp Pathol 1984; 65: 397-403.
149. Chaturvedi P, Chaturvedi UC, Mukherjee R. Transmission of dengue virus-induced helper signal to B cell via macrophages. Int J Exp Pathol 1992; 73: 773-82.
150. Gulati L, Chaturvedi UC, Mathur A. Dengue virus-induced cytotoxic factor induces macrophages to produce a cytotoxin. Immunology 1983; 49: 121-30.
151. Gulati L, Chaturvedi UC, Mathur A. Production of dengue virus-induced macrophage cytotoxin in vivo. Br J Exp Pathol 1986; 67: 269-77.
152. Dhawan R, Khanna M, Chaturvedi UC, Mathur A. Effect of dengue virus-induced cytotoxin on capillary permeability. Br J Exp Pathol (Oxford) 1990; 71: 83-8.
153. Misra A, Mukerjee R, Chaturvedi UC. Production of nitrite by dengue virus-induced cytotoxic factor. Clin ExpImmunol 1996; 104: 406-11.
154. Misra A, Mukerjee R, Chaturvedi UC. Release of reactive oxygen intermediates by dengue virus-induced macrophage cytotoxin. Int J Exp Pathol 1996; 77: 237-42.
155. Mukerjee R, Misra A, Chaturvedi UC. Dengue virus-induced cytotoxin releases nitrite by spleen cells. Int J Exp Pathol 1996; 77: 45-51.
156. Khare M, Chaturvedi UC. Role of nitric oxide in transmission of dengue virus specific suppressor signal. Indian J Exp Biol 1997; 35: 855-60.
157. Chaturvedi UC, Nagar R. Nitric oxide in dengue and dengue haemorrhagic fever: necessity or nuisance. FEMS Immunol Med Microbiol 2009; 56: 9-24.
158. Chaturvedi UC, Nagar R, Shrivastava R. Macrophage & dengue virus: Friend or foe? Indian J Med Res 2006; 124: 23-40.
159. Chaturvedi UC. Virus-induced cytotoxic factor in AIDS and dengue. Immunol Today 1986; 7: 159.
160. Chaturvedi UC. Togavirus-induced immunosuppression. In: Specter S, Bendinelli M, Friedman H, editors. Virus-induced immunosuppression. New York: Plenum Press; 1989. p. 253-83.
161. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003; 3: 791-800.
162. Sumarmo, Wulcur H, Jahja E, Gubler DJ, Sutomenggolo TS, Saroso JS. Encephalopathy associated with dengue infection. Lancet 1978; 1: 449-50.
163. Dhawan R, Chaturvedi UC, Khanna M, Mathur A. Dengue virus-induced cytokine damages the blood-brain barrier in mice. Proc Indian Natl Acad Sci 1994; 60: 45-52.
164. Basu A, Chaturvedi UC. Vascular endothelium: the battle field of dengue viruses. FEMS Immunol Med Microbiol 2008; 53: 287-9.
165. Basu A, Chaturvedi UC. Recent advances in understanding the intracellular responses to dengue virus infection. Future Virol 2010; 5: 255-7.
166. Basu A, Jain P, Gangodkar S, Shetty S, Ghosh K. Dengue 2 virus inhibits in vitro megakaryocytic colony formation and induce apoptosis in thrombopoietin-inducible megakaryocytic differentiation from cord blood CD34+ cells. FEMS Immunol Med Microbiol 2008; 53: 46-51.
167. Basu A, Jain P, Sarkar P, Gangodkar S, Deshpande D, Ganti K, et al. Dengue virus infection of SK Hep1 cells: inhibition of in-vitro angiogenesis and altered cytomorphology by expressed viral envelope glycoprotein. FEMS Immunol Med Microbiol 2011; 62: 140-7.
168. Ghosh K, Gangodkar S, Jain P, Shetty S, Ramjee S, Poddar P, et al. Imaging the interaction between dengue 2 virus and human blood platelets using atomic force and electron microscopy J Electron Microsc 2008; 57: 113-8.
169. Gangodkar S, Jain P, Dixit N, Ghosh K, Basu A. Dengue virus induced autophagosomes and changes in endomembrane ultrastructure imaged by electron tomography and whole mount grid-cell culture techniques. J Electron Microsc 2010; 59: 503-11.
170. Halstead SB, Nimmannitya S, Cohen SN. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 1970; 42: 311-28.
171. Kurane I, Ennis FE. Immunity and immunopathology in dengue virus infections. Semin Immunol 1992; 4: 121-7.
172. Chaturvedi UC, Raghupathy R, Pacsa AS, Elbishbishi EA, Agarwal R, Nagar R, et al. Shift from a Th1-type response to Th2-type in dengue haemorrhagic fever. Curr Sci 1999; 76: 63-9.
173. Kalita J, Srivastava R, Mishra MK, Basu A, Misra UK. Cytokines and chemokines in viral encephalitis: a clinicoradiological correlation. Neurosci Lett 2010; 473: 48-51.
174. Mabalirajan U, Kadhiravan T, Sharma SK, Banga A, Ghosh B. Th(2) immune response in patients with dengue during defervescence: preliminary evidence. Am J Trop Med Hyg 2005; 72: 783-5.
175. Kadhiravan T, Saxena A, Singh A, Broor S, Sharma SK, Mitra DK. Association of intracellular T(H)1-T(H)2 balance in CD4+ T-cells and MIP-1α in CD8+ T-cells with disease severity in adults with dengue. Immune Netw 2010; 10: 164-72.
176. Priyadarshini D, Gadia RR, Tripathy A, Gurukumar KR, Bhagat A, Patwardhan S, et al. Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study. PLoS One 2010; 5: e8709.
177. Raghupathy R, Chaturvedi UC, Al-Sayer H, Elbishbishi EA, Agarwal R, Nagar R, et al. Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol 1998; 56: 280-5.
178. Pasca AS, Agarwal R, Elbishbishi EA, Chaturvedi UC, Nagar R, Mustafa AS. Interleukin-12 in patients with dengue haemorrhagic fever. FEMS Immunol Med Microbiol 2000; 28: 151-5.
179. Mustafa AS, Elbishbishi EA, Agarwal R, Chaturvedi UC. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 2001; 30: 229-33.
180. Chakravarti A, Kumaria R. Circulating levels of tumour necrosis factor-alpha & interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak. Indian J Med Res 2006; 123: 25-30.
181. Agarwal R, Elbishbishi EA, Chaturvedi UC, Nagar R, Mustafa AS. Profile of transforming growth factor-beta1 in patients with dengue haemorrhagic fever. Int J Exp Pathol 1999; 80: 143-9.
182. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS. Cytokine cascade in dengue haemorrhagic fever: Implications for pathogenesis. FEMS Immunol Med Microbiol 2000; 28: 183-8.
183. Gupta N, Chaturvedi UC. Can helper T-17 cells play a role in dengue haemorrhagic fever? Indian J Med Res 2009; 130: 5-8.
184. Misra A, Mukerjee R, Chaturvedi UC. Respiratory burst by dengue virus-induced cytotoxic factor. Med Principles Pract 1998; 7: 251-60.
185. Chaturvedi UC, Dhawan R, Mukerjee R. Immunosuppression and cytotoxicity of dengue infection in the mouse model. In: Gubler DJ, Kuno G, editors. Dengue and dengue haemorrhagic fever. Wallingford, Oxon, U.K.: CAB International Press; 1997. p. 291-312.
186. Chaturvedi UC, Elbishbishi EA, Agarwal R, Mustafa AS. Cytotoxic Factor-autoantibodies: possible role in the pathogenesis of dengue haemorrhagic fever. FEMS Immunol Med Microbiol 2001; 30: 181-6.
187. Halstead SB. Dengue. Lancet 2007; 370: 1644-52.
188. Morrison J, Aguirre S, Fernandez-Sesma A. Innate immunity evasion by dengue virus. Viruses 2012; 4: 397-413.
189. Renneson J, Guabiraba R, Maillet I, Marques RE, Ivanov S, Fontaine J, et al. A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection. Am J Pathol 2011; 179: 1872-83.
190. Alagarasu K, Bachal RV, Bhagat AB, Shah PS, Dayaraj C. Elevated levels of vitamin D and deficiency of mannose binding lectin in dengue hemorrhagic fever. Virol J 2012; 9: 86-93.
191. Espada-Murao LA, Morita K. Dengue and soluble mediators of the innate immune system. Trop Med Health 2011; 39 (4 Suppl): 53-62.
192. Mishra KP, Shweta, Diwaker D, Ganju L. Dengue virus infection induces upregulation of hn RNP-H and PDIA3 for its multiplication in the host cell. Virus Res 2012; 163: 573-9.
193. Khor CC, Chau TN, Pang J, Davila S, Long HT, Ong RT, et al. Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat Genet 2011; 43: 1139-41.
194. Brown MG, Salas RA, Vickers IE, Heslop OD, Smikle MF. Dengue HLA associations in Jamaicans. West Indian Med J 2011; 60: 126-31.
195. García G, del Puerto F, Pérez AB, Sierra B, Aguirre E, Kikuchi M, et al. Association of MICA and MICB alleles with symptomatic dengue infection. Hum Immunol 2011; 72: 904-7.
196. Li J, Huang R, Liao W, Chen Z, Zhang S, Huang R. Dengue virus utilizes calcium modulating cyclophilin-binding ligand to subvert apoptosis. Biochem Biophys Res Commun 2012; 418: 622-7.
197. van de Weg CA, Koraka P, van Gorp EC, Mairuhu AT, Supriatna M, Soemantri A, et al. Lipopolysaccharide levels are elevated in dengue virus infected patients and correlate with disease severity. J Clin Virol 2012; 53: 38-42.
198. Singh KR, Paul SD. Isolation of dengue viruses in Aedes albopictus cell cultures. Bull World Health Organ 1969; 40: 982-3.
199. Chakravarti A, Kumar A, Malik S. Detection of dengue infection by combining the use of an NS1 antigen based assay with antibody detection. Southeast Asian J Trop Med Public Health 2011; 42: 297-302.
200. Mishra B, Sharma M, Pujhari SK, Ratho RK, Gopal DS, Kumar CN, et al. Utility of multiplex reverse transcriptase-polymerase chain reaction for diagnosis and serotypic characterization of dengue and chikungunya viruses in clinical samples. Diagn Microbiol Infect 2011; 71: 118-25.
201. Chaudhary R, Khetan D, Sinha S, Sinha P, Sonker A, Pandey P, et al. Transfusion support to Dengue patients in a hospital based blood transfusion service in north India. Transfus Apher Sci 2006; 35: 239-44.
202. Kharya G, Yadav SP, Katewa S, Sachdeva A. Management of severe refractory thrombocytopenia in dengue hemorrhagic fever with intravenous anti-D immune globulin. Pediatr Hematol Oncol 2011; 28: 727-32.
203. Shrivastava R, Nagar R, Ravishankar GA, Upreti RK, Chaturvedi UC Effect of pretreatment with chromium picolinate on haematological parameters during dengue virus infection in mice. Indian J Med Res 2007; 126: 440-6.
204. Jain M, Ganju L, Katiyal A, Padwad Y, Mishra KP, Chanda S, et al. Effect of Hippophae rhamnoides leaf extract against dengue virus infection in human blood-derived macrophages. Phytomedicine 2008; 15: 793-9.
205. Guy B, Barrere B, Malinowski C, Saville M, Teyssou R, Lang J. From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine. Vaccine 2011; 29: 7229-41.
206. Etemad B, Batra G, Raut R, Dahiya S, Khanam S, Swaminathan S, et al. An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes. Am J Trop Med Hyg 2008; 79: 353-63.
207. Tripathi NK, Babu JP, Shrivastva A, Parida M, Jana AM, Rao PV. Production and characterization of recombinant dengue virus type 4 envelope domain III protein. J Biotechnol 2008; 134: 278-86.
208. Pattnaik P, Babu JP, Verma SK, Tak V, Rao PV. Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 846: 184-94.
209. Babu JP, Pattnaik P, Gupta N, Shrivastava A, Khan M, Rao PV. Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice. Vaccine 2008; 26: 4655-63.
210. Jaiswal S, Khanna N, Swaminathan S. High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli. Protein Expr Purif 2004; 33: 80-91.
211. Ananda Rao R, Swaminathan S, Fernando S, A Jana AM, Khanna N. A custom-designed recombinant multiepitope protein as a dengue diagnostic reagent. Protein Exp Purif 2005; 41: 136-41.
212. Ananda Rao R, Swaminathan S, Fernando S, Jana AM, Khanna N. A recombinant multiepitope protein for the early detection of dengue infections. Clin Vaccine Immunol 2006; 13: 59-67.
213. Kolli R, Khanam S, Jain M, Ganju L, Sai Ram M, Khanna NV, et al. A synthetic dengue virus antigen elicits enhanced antibody titers when linked to, but not mixed with, Mycobacterium tuberculosis HSP70 domain II. Vaccine 2006; 24: 4716-26.
214. Khanam S, Etemad B, Khanna N, Swaminathan S. A bivalent antigen composed of linked envelope domains III of two dengue virus serotypes elicits neutralizing antibodies specific to both constituent serotypes. Am J Trop Med Hyg 2006; 74: 266-77.
215. Hapugoda MD, Batra G, Abeyewickreme W, Swaminathan S, Khanna N. Single antigen detects both immunoglobulin M (IgM) and IgG antibodies elicited by all four dengue virus serotypes. Clin Vaccine Immunol 2007; 14: 1505-14.
216. Batra G, Nemani SK, Tyagi P, Swaminathan S, Khanna N. Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera. BMC Infect Dis 2011; 11: 64.
217. Batra G, Talha SM, Nemani SK, Dhar N, Swaminathan S, Khanna N. Expression, purification and characterization of in vivo biotinylated dengue virus envelope domain III based tetravalent antigen. Protein Exp Purif 2010; 74: 99-105.
218. Bisht H, Chugh DA, Swaminathan S, Khanna N. Expression and purification of dengue virus type 2 envelope protein as a fusion with hepatitis B surface antigen in Pichia pastoris. Protein Exp Purif 2001; 23: 84-96.
219. Bisht H, Chugh DA, Raje M, Swaminathan S, Khanna N. Recombinant dengue virus type 2 envelope/hepatitis B surface antigen hybrid protein expressed in Pichia pastoris can function as a bivalent immunogen. J Biotechnol 2002; 99: 97-110.
220. Batra G, Raut R, Dahiya S, Kamran N, Swaminathan S, Khanna N. Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies. J Virol Methods 2010; 167: 10-6.
221. Batra G, Gurramkonda C, Nemani SK, Jain SK, Swaminathan S, Khanna N. Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris. J Biosci Bioeng 2010; 110: 408-14.
222. Jaiswal S, Khanna N, Swaminathan S. A replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2. J Virol 2003; 77: 12907-13.
223. Khanam S, Khanna N, Swaminathan S. Induction of antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors. Vaccine 2006; 24: 6513-25.
224. Khanam S, Rajendra P, Khanna N, Swaminathan S. An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypes. BMC Biotechnol 2007; 7: 10.
225. Khanam S, Pilankatta R, Khanna N, Swaminathan S. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity. Vaccine 2009; 27: 6011-21.
226. Tripathi NK, Shrivastava A, Biswal KC, Rao PV. Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli. Biotechnol J 2011; 6: 604-8.
227. Kumbhat S, Sharma K, Gehlot R, Solanki A, Joshi V. Surface plasmon resonance based immunosensor for serological diagnosis of dengue virus infection. J Pharm Biomed Anal 2010; 52: 255-9.
228. Tripathi NK, Shrivastva A, Pattnaik P, Parida M, Dash PK, Gupta N, et al. Production of IgM specific recombinant dengue multiepitope protein for early diagnosis of dengue infection. Biotechnol Prog 2007; 23: 488-93.
229. Shriram AN, Sugunan AP, Manimunda SP, Vijayachari P. Community-centred approach for the control of Aedes spp. in a peri-urban zone in the Andaman and Nicobar Islands using temephos. Natl Med J India 2009; 22: 116-20.
230. Sharma K, Angel B, Singh H, Purohit A, Joshi V. Entomological studies for surveillance and prevention of dengue in arid and semi-arid districts of Rajasthan, India. J Vector Borne Dis 2008; 45: 124-32.
231. Fulmali PV, Walimbe A, Mahadev PV. Spread, establishment & prevalence of dengue vector Aedes aegypti (L.) in Konkan region, Maharashtra, India. Indian J Med Res 2008; 127: 589-601.
232. Dash AP, Chhotray GP, Mahapatra N, Hazra RK. Retrospective analysis of epidemiological investigation of Japanese encephalitis outbreak occurred in Rourkela, Orissa, India. Southeast Asian J Trop Med Public Health 2001; 32: 137-9.
233. Tikar SN, Mendki MJ, Chandel K, Parashar BD, Prakash S. Susceptibility of immature stages of Aedes (Stegomyia) aegypti; vector of dengue and chikungunya to insecticides from India. Parasitol Res 2008; 102: 907-13.
234. Mani TR, Arunachalam N, Rajendran R, Satyanarayana K, Dash AP. Efficacy of thermal fog application of deltacide, asynergized mixture of pyrethroids, against Aedes aegypti, the vector of dengue. Trop Med Int Health 2005; 10: 1298-304.
235. Rajkumar S, Jebanesan A. Prevention of dengue fever through plant based mosquito repellent Clausena dentata (Willd.) M. Roem (Family: Rutaceae) essential oil against Aedes aegypti l. (Diptera: Culicidae) mosquito. Eur Rev Med Pharmacol Sci 2010; 14: 231-4.
236. Rajkumar S, Jebanesan A, Bioactivity of flavonoid compounds from Poncirus trifoliata L. (Family: Rutaceae) against the dengue vector, Aedes aegypti L. (Diptera: Culicidae). Parasitol Res 2008; 104: 19-25.
237. Govindarajan M, Karuppannan P. Mosquito larvicidal and ovicidal properties of Eclipta alba (L.) Hassk (Asteraceae) against chikungunya vector, Aedes aegypti (Linn.) (Diptera: Culicidae). Asian Pac J Trop Med 2011; 4: 24-8.
238. Barik TK, Kamaraju R, Gowswami A. Silica nanoparticle: a potential new insecticide for mosquito vector control. Parasitol Res 2012; [Epub ahead of print].
239. Ashok Kumar V, Rajendran R, Manavalan R, Tewari SC, Arunachalam N, Ayanar K, et al. Studies on community knowledge and behavior following a dengue epidemic in Chennai city, Tamil Nadu, India. Trop Biomed 2010; 27: 330-6.